BARCLAYS PLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Position in CRVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,717,289

+$1,150,848 QoQ

Shares Held

315,749

+29.5% QoQ

Ownership

0.375%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 172 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,036 across 455 Biotechnology names. CRVS ranks #44 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,717,289	315,749	+29.5%	Shares	Defined	2026-08-14
2026-03-31	$3,566,441	243,776	-38.2%	Shares	Defined	2026-05-15
2025-12-31	$3,039,698	394,766	+39476500.0%	Shares	Sole	2026-02-13
2022-09-30	$0	1	-100.0%	Shares	Sole	2022-11-03
2022-06-30	$9,573	9,671	-12.8%	Shares	Sole	2022-08-12
2022-03-31	$18,196	11,096	-4.3%	Shares	Sole	2022-05-16
2021-12-31	$27,938	11,593	+1159200.0%	Shares	Sole	2022-02-14
2021-09-30	$4	1	-75.0%	Shares	Sole	2021-11-09
2021-06-30	$10	4	-99.3%	Shares	Sole	2021-08-13
2021-03-31	$1,653	537	+13325.0%	Shares	Sole	2021-05-13
2020-12-31	$14	4	0.0%	Shares	Sole	2021-02-11
2020-09-30	$16	4	-99.8%	Shares	Sole	2020-11-12
2020-06-30	$6,008	2,209	+19981.8%	Shares	Sole	2020-08-12
2020-03-31	$23	11	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.